Jan Heyckendorf Selected Research

Jan Heyckendorf Research Topics

20	Tuberculosis (Tuberculoses) 01/2022 - 01/2014
7	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2022 - 04/2015
6	Infections 01/2022 - 01/2014
5	Extensively Drug-Resistant Tuberculosis 01/2018 - 08/2014
3	Pulmonary Tuberculosis 11/2019 - 01/2014
3	Communicable Diseases (Infectious Diseases) 01/2016 - 08/2014
2	Pulmonary Aspergillosis 01/2018 - 01/2016
2	Lung Diseases (Lung Disease) 06/2017 - 01/2016
2	Latent Infection 07/2016 - 01/2016
1	Pneumoperitoneum 09/2022
1	Pneumothorax 09/2022
1	Disease Progression 06/2021
1	Pulmonary Embolism 03/2021
1	Critical Illness (Critically Ill) 12/2020
1	COVID-19 12/2020
1	Meningeal Tuberculosis (Tuberculous Meningitis) 04/2020
1	Clinical Deterioration 04/2020
1	Seizures (Absence Seizure) 04/2020
1	Tuberculoma 04/2020
1	Paracoccidioidomycosis (South American Blastomycosis) 01/2018
1	Mycoses (Diseases, Fungus) 01/2018
1	Histoplasmosis 01/2018
1	Sporotrichosis 01/2018
1	talaromycosis 01/2018
1	Coccidioidomycosis 01/2018
1	Blastomycosis 01/2018
1	Persistent Infection 07/2016
1	Bronchiectasis 07/2016
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2016
1	Virus Diseases (Viral Diseases) 10/2015
1	Neoplasms (Cancer) 10/2015
1	Coinfection 09/2015
1	Drug-Related Side Effects and Adverse Reactions 08/2014
1	Pulmonary Arterial Hypertension 04/2014
1	Inflammation (Inflammations) 04/2014
1	Pulmonary Hypertension 04/2014

10	Pharmaceutical PreparationsIBA 01/2022 - 08/2014
5	bedaquiline (R207910)IBA 01/2022 - 04/2015
5	Biomarkers (Surrogate Marker)IBA 06/2021 - 04/2014
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 06/2017
3	Isoniazid (Ftivazide)FDA LinkGeneric 11/2019 - 10/2017
2	CytokinesIBA 01/2022 - 01/2018
2	Rifampin (Rifampicin)FDA LinkGeneric 10/2021 - 11/2019
2	InterferonsIBA 12/2020 - 01/2016
2	VaccinesIBA 01/2018 - 10/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 07/2016 - 08/2014
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2022
1	tuberculostearic acidIBA 01/2022
1	theasinensin AIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Indicators and Reagents (Reagents)IBA 10/2021
1	Biological ProductsIBA 06/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 04/2020
1	Ethambutol (Myambutol)FDA LinkGeneric 11/2019
1	Pyrazinamide FDA LinkGeneric 11/2019
1	Nucleic AcidsIBA 01/2018
1	Fluconazole (Zonal)FDA LinkGeneric 01/2018
1	Itraconazole (Sporanox)FDA LinkGeneric 01/2018
1	galactomannanIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Chimeric Antigen ReceptorsIBA 10/2015
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2015
1	Interleukin-2 (IL2)IBA 09/2015
1	PNU-100480IBA 04/2015
1	OPC-67683IBA 04/2015
1	FluoroquinolonesIBA 04/2015
1	posizolidIBA 04/2015
1	pretomanidIBA 04/2015
1	Linezolid (Zyvox)FDA Link 04/2015
1	Fibrinogen (Factor I)FDA Link 04/2014
1	AcidsIBA 01/2014
1	AntigensIBA 01/2014

13	Therapeutics 01/2022 - 01/2014
4	Duration of Therapy 12/2021 - 08/2014
3	Precision Medicine 06/2021 - 01/2016
1	Surgical Instruments (Clip) 09/2022
1	Endarterectomy (Thromboendarterectomy) 03/2021
1	Immunotherapy 10/2015